Hormonal Receptor Immunochemistry Heterogeneity and (18)F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Brea...

por Aide, Nicolas, Elie, Nicolas, Blanc-Fournier, Cécile, Levy, Christelle, Salomon, Thibault, Lasnon, Charline
Publicado 2021

Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics

por Aide, Nicolas, Salomon, Thibault, Blanc-Fournier, Cécile, Grellard, Jean-Michel, Levy, Christelle, Lasnon, Charline
Publicado 2018

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Pacl...

por Bertucci, Alexandre, Bertucci, François, Zemmour, Christophe, Lerebours, Florence, Pierga, Jean-Yves, Levy, Christelle, Dalenc, Florence, Grenier, Julien, Petit, Thierry, Berline, Marguerite, Gonçalves, Anthony
Publicado 2020

Staging the axilla in breast cancer patients with (18)F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

por Bellevre, Dimitri, Blanc Fournier, Cécile, Switsers, Odile, Dugué, Audrey Emmanuelle, Levy, Christelle, Allouache, Djelila, Desmonts, Cédric, Crouet, Hubert, Guilloit, Jean-Marc, Grellard, Jean-Michel, Aide, Nicolas
Publicado 2014

UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)

por Vaz-Luis, Ines, Cottu, Paul, Mesleard, Christel, Martin, Anne Laure, Dumas, Agnes, Dauchy, Sarah, Tredan, Olivier, Levy, Christelle, Adnet, Johan, Rousseau Tsangaris, Marina, Andre, Fabrice, Arveux, Patrick
Publicado 2019

Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study

por Rogé, Maximilien, Salleron, Julia, Kirova, Youlia, Guigo, Marin, Cailleteau, Axel, Levy, Christelle, Leheurteur, Marianne, Nebbache, Rafik, Rivin Del Campo, Eleonor, Lazarescu, Ioana, Servagi, Stéphanie, Aumont, Maud, Thariat, Juliette, Thureau, Sébastien
Publicado 2022

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors

por Rottier, Pauline, Emile, George, Johnson, Alison, Levy, Christelle, Allouache, Djelila, Hrab, Ioana, Segura, Carine, Morel, Adeline, Villemin, Maud, Dubot-Poitelon, Coraline, Boismoreau, Louis, Cherifi, François, Lequesne, Justine, Da Silva, Angélique
Publicado 2023

Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation

por Clément-Zhao, Alice, Tanguy, Marie-Laure, Cottu, Paul, De La Lande, Brigitte, Bontemps, Patrick, Lemanski, Claire, Baumann, Pierre, Savignoni, Alexia, Levy, Christelle, Peignaux, Karine, Reynaud-Bougnoux, Agnès, Gobillion, Aline, Kirova, Youlia
Publicado 2019

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study

por Sabatier, Renaud, Vicier, Cécile, Garnier, Séverine, Guille, Arnaud, Carbuccia, Nadine, Isambert, Nicolas, Dalenc, Florence, Robert, Marie, Levy, Christelle, Pakradouni, Jihane, Adelaïde, José, Chaffanet, Max, Sfumato, Patrick, Mamessier, Emilie, Bertucci, François, Goncalves, Anthony
Publicado 2022

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS)...

por Forbes, John F, Sestak, Ivana, Howell, Anthony, Bonanni, Bernardo, Bundred, Nigel, Levy, Christelle, von Minckwitz, Gunter, Eiermann, Wolfgang, Neven, Patrick, Stierer, Michael, Holcombe, Chris, Coleman, Robert E, Jones, Louise, Ellis, Ian, Cuzick, Jack
Publicado 2016

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast...

por Goldstein, Lori J., Mansutti, Mauro, Levy, Christelle, Chang, Jenny C., Henry, Stephanie, Fernandez-Perez, Isaura, Prausovà, Jana, Staroslawska, Elzbieta, Viale, Giuseppe, Butler, Beth, McCanna, Susan, Ruffini, Pier Adelchi, Wicha, Max S., Schott, Anne F.
Publicado 2021

Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task

por Duivon, Mylène, Perrier, Joy, Segura-Djezzar, Carine, Joly, Florence, Rehel, Stéphane, Berthomier, Christian, Grellard, Jean-Michel, Clarisse, Bénédicte, Geffrelot, Julien, Emile, George, Lévy, Christelle, Viader, Fausto, Eustache, Francis, Desgranges, Béatrice, Rauchs, Géraldine, Giffard, Bénédicte
Publicado 2022

Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study

por Duivon, Mylène, Perrier, Joy, Joly, Florence, Licaj, Idlir, Grellard, Jean-Michel, Clarisse, Bénédicte, Lévy, Christelle, Fleury, Philippe, Madeleine, Sophie, Lefèvre, Nicolas, Rauchs, Géraldine, Lecouvey, Grégory, Fraisse, Florence, Viader, Fausto, Eustache, Francis, Desgranges, Béatrice, Giffard, Bénédicte
Publicado 2018

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

por Cherifi, François, Da Silva, Angélique, Johnson, Alison, Blanc-Fournier, Cécile, Abramovici, Olivia, Broyelle, Antonin, Levy, Christelle, Allouache, Djelila, Hrab, Ioana, Segura, Carine, Morel, Adeline, Villemin, Maud, Boscher, Clémence, Dubot-Poitelon, Coraline, Rottier, Pauline, Lequesne, Justine, Emile, George
Publicado 2022

Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes

por Carausu, Marcela, Carton, Matthieu, Diéras, Véronique, Petit, Thierry, Guiu, Séverine, Gonçalves, Anthony, Augereau, Paule, Ferrero, Jean Marc, Levy, Christelle, Ung, Mony, Desmoulins, Isabelle, Debled, Marc, Bachelot, Thomas, Pistilli, Barbara, Frenel, Jean-Sébastien, Mailliez, Audrey, Chevrot, Michaël, Cabel, Luc
Publicado 2022

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

por Clatot, Florian, Perdrix, Anne, Beaussire, Ludivine, Lequesne, Justine, Lévy, Christelle, Emile, George, Bubenheim, Michael, Lacaille, Sigrid, Calbrix, Céline, Augusto, Laetitia, Guillemet, Cécile, Alexandru, Cristina, Fontanilles, Maxime, Sefrioui, David, Burel, Lucie, Guénot, Sabine, Richard, Doriane, Sarafan-Vasseur, Nasrin, Di Fiore, Frédéric
Publicado 2020

Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3‐arm randomized trial

por Dos Santos, Mélanie, Hardy‐Léger, Isabelle, Rigal, Olivier, Licaj, Idlir, Dauchy, Sarah, Levy, Christelle, Noal, Sabine, Segura, Carine, Delcambre, Corinne, Allouache, Djelila, Parzy, Aurélie, Barriere, Jérôme, Petit, Thierry, Lange, Marie, Capel, Aurélie, Clarisse, Bénédicte, Grellard, Jean Michel, Lefel, Johan, Joly, Florence
Publicado 2020

Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational s...

por Baffert, Sandrine, Cottu, Paul, Kirova, Youlia M, Mercier, Florence, Simondi, Cécile, Bachelot, Thomas, Le Rhun, Emilie, Levy, Christelle, Gutierrez, Maya, Madranges, Nicolas, Moldovan, Cristian, Coudert, Bruno, Spaëth, Dominique, Serin, Daniel, Cotté, François-Emery, Benjamin, Laure, Maillard, Cathie, Laulhere-Vigneau, Sabine, Durand-Zaleski, Isabelle
Publicado 2013

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer

por Lapidari, Pietro, Gbenou, Arnauld, Havas, Julie, Martin, Elise, Pistilli, Barbara, Martin, Anne-Laure, Everhard, Sibille, Coutant, Charles, Cottu, Paul, Lesur, Anne, Lerebours, Florence, Tredan, Olivier, Vanlemmens, Laurence, Jouannaud, Christelle, Levy, Christelle, Rigal, Olivier, Fournier, Marion, Andre, Fabrice, Vaz-Luis, Ines, Di Meglio, Antonio
Publicado 2021

Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1

por Ciruelos, Eva Maria, Rugo, Hope S., Mayer, Ingrid A., Levy, Christelle, Forget, Frédéric, Delgado Mingorance, Juan Ignacio, Safra, Tamar, Masuda, Norikazu, Park, Yeon Hee, Juric, Dejan, Conte, Pierfranco, Campone, Mario, Loibl, Sibylle, Iwata, Hiroji, Zhou, Xiaolei, Park, Jinhee, Ridolfi, Antonia, Lorenzo, Ines, André, Fabrice
Publicado 2021